Do you consent to this website placing cookies on your device? You can find out more by reading our cookies policy.
We're celebrating the 50th anniversary of our founding treaty, the Treaty of Almelo.
Urenco ChemPlants owns and will operate our most recent nuclear new build, Urenco’s Tails Management Facility.
Our online annual sustainability report highlights our achievements in delivering for a net zero world.
We announced our results for the full year ended 31 December 2021 on 10 March 2022.
Diversity and inclusion is a high priority as we want to create a workforce that reflects the society in which we operate.
We have a proud history as a leading nuclear services technology company for 50 years.
Urenco was founded following the signing of the Treaty of Almelo by the governments of Germany, the Netherlands and the UK.
We delivered on our first SWU contract from pilot plant production at Urenco Nederland and Urenco UK.
Our commercial scale demonstration plants at Urenco Nederland and Urenco UK were formally installed.
Our German enrichment facility, Urenco Deutschland, began production and we opened our US marketing office.
The production of stable isotopes for medical, research and industrial applications started at Urenco Nederland.
We began production at our US enrichment facility, UUSA. To date, it is the only commercial enrichment facility in the USA.
Urenco Nuclear Stewardship, responsible for the management of nuclear materials, decommissioning and recycling, began operations.
We opened our Tails Management Facility, responsible for deconverting the by-product of our enrichment services for long-term storage.
Sign up to our newsletter by entering your email address below.